Patent Assignment
Reel/Frame 055694/0903
Certificate of Administrative Dissolution
Recorded: 2021-03-23
Pages: 4
Assignor
DILORENZO BIOMEDICAL, LLC
Executed: 2014-09-02
Assignee
DILORENZO, DANIEL J
PO BOX 1626, LOMA LINDA, CALIFORNIA, 92354-1626
Covered Properties
(13)
Apparatus and Method for Closed-Loop Intracranical Stimulation for Optimal Control of Neurological Disease
Patent:
6,366,813 →
Application:
09/340,326 →
Optimal Method and Apparatus for Neural Modulation for the Treatment of Neurological Disease, Particularly Movement Disorders
Method and Apparatus for Neuromodulation and Phsyiologic Modulation for the Treatment of Metabolic and Neuropsychiatric Disease
Apparatus and Method for Closed-Loop Intracranial Stimulation for Optimal Control of Neurological Disease
Apparatus and Method for Closed-Loop Intracranial Stimulation for Optimal Control of Neurological Disease
Methods and Systems for Predicting Future Symptomatology in a Patient Suffering from a Neurological or Psychiatric Disorder
Closed-Loop Feedback-Driven Neuromodulation
Patent:
7,324,851 →
Application:
10/858,899 →
Method and Apparatus for Neuromodulation and Phsyiologic Modulation for the Treatment of Metabolic and Neuropsychiatric Disease
Patent:
7,529,582 →
Application:
10/872,549 →
Closed-Loop Feedback-Driven Neuromodulation
Closed-Loop Autonomic Neuromodulation for Optimal Control of Neurological and Metabolic Disease
Patent:
7,974,696 →
Application:
11/187,315 →
Closed-loop feedback-driven sympathetic neuromodulation for affect control
Patent:
9,345,880 →
Application:
11/333,979 →
Method, Apparatus, Surgical Technique, and Optimal Stimulation Parameters for Noninvasive & Minimally Invasive Autonomic Vector Neuromodulation for Physiologic Optimization and for the Treatment of Obesity, Cardiac Disease, Pulmonary Disorders, Hypertension, and Other Conditions
Application:
16/286,570 →
Publication:
US 2019/0329042
Method, Apparatus, Surgical Technique, and Optimal Stimulation Parameters for Noninvasive & Minimally Invasive Autonomic Vector Neuromodulation for the Treatment of Obesity, Cardiac Disease, Pulmonary Disorders, Hypertension, and Other Conditions
Application:
16/286,582 →
Publication:
US 2020/0268536
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Sep 14, 2012
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 028959/0395 →
Patent Security Agreement
Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
Patent Security Agreement
Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
Assignment of Assignor's Interest
Mar 23, 2021
From: DILORENZO, DANIEL J
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 055692/0834 →
Assignment of Contract
Mar 23, 2021
From: DILORENZO, DANIEL J
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 055694/0913 →
Security Interest
Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
Release of Security Interest
Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
Release of Security Interest
Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
Security Interest
Feb 16, 2024
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 066484/0594 →
Change of Name
Feb 16, 2024
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 066624/0288 →
Change of Name
Feb 16, 2024
From: BIONEURONICS CORPORATION
To: NEUROVISTA CORPORATION
Reel/Frame 066624/0280 →
Assignment of Assignor's Interest
Feb 16, 2024
From: DILORENZO, DANIEL JOHN
To: BIONEURONICS CORPORATION
Reel/Frame 066621/0320 →
Assignment of Assignor's Interest
Feb 16, 2024
From: DILORENZO, DANIEL JOHN
To: BIONEURONICS CORPORATION
Reel/Frame 066621/0207 →
Assignment of Assignor's Interest
Feb 16, 2024
From: NEUROVISTA CORPORATION
To: CYBERONICS, INC.
Reel/Frame 066484/0639 →
Assignment of Assignor's Interest
May 23, 2024
From: LIVANOVA INC.; LIVANOVA USA INC.
To: DILORENZO BIOMEDICAL, LLC
Reel/Frame 067508/0068 →
Release of Security Interest
Oct 30, 2024
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: LIVANOVA USA, INC.
Reel/Frame 069072/0874 →